European Companies Search Engine

19 EU fundings (€176,436): Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine … BdlYear 2016 EU Research and Innovation programme "Horizon"

Text

Region Hovedstaden, Hillerod, Denmark

15/12/2016 EU funding (€10M): Healthy minds from 0-100 years: Optimising the use of European brain imaging cohorts
01/04/2016 EU funding (€11M): Remote Assessment of Disease and Relapse in Central Nervous System Disorders
19/12/2016 EU funding (€14.7M): Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine
19/12/2016 EU funding (€2,500,000): Reaching the effects of gastric bypass on diabetes and obesity without surgery
02/05/2016 EU funding (€3,716,533): Metal oxide Aided Subsurface Remediation: From Invention to Injection
18/10/2016 EU funding (€3,828,131): Lifestyle intervention in the perioperative process through digital service
26/09/2016 EU funding (€3,971,595): Technology Enabled Adolescent Mental Health
01/12/2016 EU funding (€3,996,780): Glaucoma – Advanced, LAbel-free High resolution Automated OCT Diagnostics
15/12/2016 EU funding (€49.9M): European Human Biomonitoring Initiative
01/01/2016 EU funding (€5,250,000): Targeting epigenetic REPROGRamming of innate immune cells in Atherosclerosis Management and other chronic inflammatory diseases
19/12/2016 EU funding (€5,913,923): Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial
01/01/2016 EU funding (€5,925,000): Comorbidity and Synapse Biology in Clinically Overlapping Psychiatric Disorders
15/12/2016 EU funding (€5,934,086): Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina A phase II randomized, double-blinded, placebo-controlled study
01/01/2016 EU funding (€5,983,808): Multi-modal, Endoscopic Biophotonic Imaging of Bladder Cancer for Point-of-Care Diagnosis
01/01/2016 EU funding (€5,999,800): “In Vivo Click PET Imaging Agents”: Improving clinical companion diagnostics
15/12/2016 EU funding (€6,195,231): Transcranial brain stimulation as innovative therapy for chronic pediatric neuropsychiatric disorder – STIPED
01/01/2016 EU funding (€6,305,654): GALAXY: Gut-and-liver axis in alcoholic liver fibrosis
19/12/2016 EU funding (€9,713,230): RECAP preterm: Research on European Children and Adults born Preterm
15/12/2016 EU funding (€9,992,881): European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment

This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Region Hovedstaden, Hillerød, Denmark.

Creative Commons License The visualizations for "Region Hovedstaden - 19 EU fundings (€176,436): Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine …" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.